Liraglutide after diet-induced weight loss for pain and weight control in knee osteoarthritis: a randomized controlled trial

Weight loss is critical for preventing and managing obesity-related diseases. There is a notable lack of valid and reliable means to manage patients with overweight/obesity and knee osteoarthritis (KOA). To determine the efficacy and safety of liraglutide in a 30 mg/d dosing in patients with overwei...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of clinical nutrition 2021-02, Vol.113 (2), p.314-323
Hauptverfasser:	Gudbergsen, Henrik, Overgaard, Anders, Henriksen, Marius, Wæhrens, Eva Ejlersen, Bliddal, Henning, Christensen, Robin, Nielsen, Sabrina Mai, Boesen, Mikael, Knop, Filip Krag, Astrup, Arne, Rasmussen, Marianne Uggen, Bartholdy, Cecilie, Daugaard, Cecilie Laubjerg, Ellegaard, Karen, Heitmann, Berit Lilienthal, Bartels, Else Marie, Danneskiold-Samsøe, Bente, Kristensen, Lars Erik
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse events Aged Antidiabetics Arthritis Biomedical materials Body weight Body weight loss Clinical trials Diet Diet, Reducing Female Gastrointestinal system Humans Hypoglycemic Agents - therapeutic use intervention Knee liraglutide Liraglutide - therapeutic use Male Middle Aged Obesity Osteoarthritis Osteoarthritis, Knee - therapy Overweight Pain Pain - drug therapy Placebos Weight control Weight loss Weight Loss - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!